Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2005 1
2006 1
2007 1
2008 1
2009 2
2010 1
2011 3
2012 2
2013 3
2014 2
2015 4
2016 3
2017 4
2018 3
2019 8
2020 18
2021 13
2022 11
2023 20
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Page 1
Asthma in Adults.
Mosnaim G. Mosnaim G. N Engl J Med. 2023 Sep 14;389(11):1023-1031. doi: 10.1056/NEJMcp2304871. N Engl J Med. 2023. PMID: 37703556 Review. No abstract available.
Digital inhalers for asthma management.
Mosnaim G, Rathkopf M. Mosnaim G, et al. Curr Opin Pulm Med. 2024 May 1;30(3):330-335. doi: 10.1097/MCP.0000000000001056. Epub 2024 Feb 21. Curr Opin Pulm Med. 2024. PMID: 38411213 Review.
Work Group Report: COVID-19: Unmasking Telemedicine.
Hare N, Bansal P, Bajowala SS, Abramson SL, Chervinskiy S, Corriel R, Hauswirth DW, Kakumanu S, Mehta R, Rashid Q, Rupp MR, Shih J, Mosnaim GS. Hare N, et al. Among authors: mosnaim gs. J Allergy Clin Immunol Pract. 2020 Sep;8(8):2461-2473.e3. doi: 10.1016/j.jaip.2020.06.038. Epub 2020 Jun 27. J Allergy Clin Immunol Pract. 2020. PMID: 32603900 Free PMC article. Review.
Asthma in Adults. Reply.
Mosnaim G. Mosnaim G. N Engl J Med. 2023 Nov 30;389(22):2112-3. doi: 10.1056/NEJMc2312345. N Engl J Med. 2023. PMID: 38048203 No abstract available.
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
Greenhawt M, Dribin TE, Abrams EM, Shaker M, Chu DK, Golden DBK, Akin C, Anagnostou A, ALMuhizi F, Alqurashi W, Arkwright P, Baldwin JL, Banerji A, Bégin P, Ben-Shoshan M, Bernstein J, Bingemann TA, Bindslev-Jensen C, Blumenthal K, Byrne A, Cahill J, Cameron S, Campbell D, Campbell R, Cavender M, Chan ES, Chinthrajah S, Comberiati P, Eastman JJ, Ellis AK, Fleischer DM, Fox A, Frischmeyer-Guerrerio PA, Gagnon R, Garvey LH, Grayson MH, Isabwe GAC, Hartog N, Hendron D, Horner CC, Hourihane JO, Iglesia E, Kan M, Kaplan B, Katelaris CH, Kim H, Kelso JM, Khan DA, Lang D, Ledford D, Levin M, Lieberman JA, Loh R, Mack DP, Mazer B, Mody K, Mosnaim G, Munblit D, Mustafa SS, Nanda A, Nathan R, Oppenheimer J, Otani IM, Park M, Pawankar R, Perrett KP, Peter J, Phillips EJ, Picard M, Pitlick M, Ramsey A, Rasmussen TH, Rathkopf MM, Reddy H, Robertson K, Rodriguez Del Rio P, Sample S, Sheshadri A, Sheik J, Sindher SB, Spergel JM, Stone CA, Stukus D, Tang MLK, Tracy JM, Turner PJ, Vander Leek TK, Wallace DV, Wang J, Wasserman S, Weldon D, Wolfson AR, Worm M, Yacoub MR. Greenhawt M, et al. Among authors: mosnaim g. J Allergy Clin Immunol. 2023 Aug;152(2):309-325. doi: 10.1016/j.jaci.2023.05.019. Epub 2023 Jun 7. J Allergy Clin Immunol. 2023. PMID: 37295474 Free PMC article. Review.
Early Outpatient Treatment for Covid-19 with Convalescent Plasma.
Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. Sullivan DJ, et al. Among authors: mosnaim gs. N Engl J Med. 2022 May 5;386(18):1700-1711. doi: 10.1056/NEJMoa2119657. Epub 2022 Mar 30. N Engl J Med. 2022. PMID: 35353960 Free PMC article. Clinical Trial.
Social Determinants of Health and COVID-19.
Mosnaim G, Carrasquel M, Wolfson AR, Peters J, Lang D, Rathkopf M. Mosnaim G, et al. J Allergy Clin Immunol Pract. 2023 Nov;11(11):3347-3355. doi: 10.1016/j.jaip.2023.07.027. Epub 2023 Jul 26. J Allergy Clin Immunol Pract. 2023. PMID: 37507069
Asthma Control-Time to Rethink Definitions and Criteria.
Mosnaim G, Stempel H, Szefler SJ, Stempel DA. Mosnaim G, et al. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1522-1523. doi: 10.1016/j.jaip.2019.02.001. J Allergy Clin Immunol Pract. 2019. PMID: 31076062 No abstract available.
Early antibody treatment, inflammation, and risk of post-COVID conditions.
Gebo KA, Heath SL, Fukuta Y, Zhu X, Baksh S, Abraham AG, Habtehyimer F, Shade D, Ruff J, Ram M, Laeyendecker O, Fernandez RE, Patel EU, Baker OR, Shoham S, Cachay ER, Currier JS, Gerber JM, Meisenberg B, Forthal DN, Hammitt LL, Huaman MA, Levine A, Mosnaim GS, Patel B, Paxton JH, Raval JS, Sutcliffe CG, Anjan S, Gniadek T, Kassaye S, Blair JE, Lane K, McBee NA, Gawad AL, Das P, Klein SL, Pekosz A, Bloch EM, Hanley D, Casadevall A, Tobian AAR, Sullivan DJ; CSSC-004 Consortium. Gebo KA, et al. Among authors: mosnaim gs. mBio. 2023 Oct 31;14(5):e0061823. doi: 10.1128/mbio.00618-23. Epub 2023 Sep 19. mBio. 2023. PMID: 37724870 Free PMC article. Clinical Trial.
The One Health approach for allergic diseases and asthma.
Jutel M, Mosnaim GS, Bernstein JA, Del Giacco S, Khan DA, Nadeau KC, Pali-Schöll I, Torres MJ, Zemelka-Wiacek M, Agache I. Jutel M, et al. Among authors: mosnaim gs. Allergy. 2023 Jul;78(7):1777-1793. doi: 10.1111/all.15755. Epub 2023 May 9. Allergy. 2023. PMID: 37119496
95 results